FDA rejected Musk’s Neuralink for human testing trials

Published March 2, 2023 5:27pm ET



The Food and Drug Administration rejected the application of an Elon Musk-funded startup that intended to install computer interfaces into the human brain.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.